ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

CCOPs Get $1 Million More, Payline Raised To 228 Plus Exceptions

May 29, 1987

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

IM Recommends Pay Increase for Many At NIH, Other Steps; Adamson Objects To “Primrose Path Of Centralization

March 3, 1989